Literature DB >> 24046195

Hepcidin--a well-known iron biomarker with prognostic implications in chronic kidney disease.

Martin Wagner1, Damien Ashby.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24046195     DOI： 10.1093/ndt/gft330

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  5 in total

1.  A single dialysis session of hemodiafiltration with sorbent-regenerated endogenous ultrafiltrate reinfusion (HFR) removes hepcidin more efficiently than bicarbonate hemodialysis: a new approach to containing hepcidin burden in dialysis patients?

Authors:  Nicola Tessitore; Albino Poli; Valeria Bedogna; Luca Corazza; Natascia Campostrini; Mauro Atti; Luisa Sereni; Annalisa Castagna; Domenico Girelli; Giuseppina Pessolano; Antonio Lupo
Journal:  J Nephrol       Date:  2017-03-28       Impact factor: 3.902

Review 2.  Balance of cardiac and systemic hepcidin and its role in heart physiology and pathology.

Authors:  Driton Vela
Journal:  Lab Invest       Date:  2017-10-23       Impact factor: 5.662

Review 3.  Iron dosing in kidney disease: inconsistency of evidence and clinical practice.

Authors:  Adam E Gaweda; Yelena Z Ginzburg; Yossi Chait; Michael J Germain; George R Aronoff; Eliezer Rachmilewitz
Journal:  Nephrol Dial Transplant       Date:  2014-05-12       Impact factor: 5.992

4.  Hepcidin-25 in diabetic chronic kidney disease is predictive for mortality and progression to end stage renal disease.

Authors:  Martin Wagner; Damien R Ashby; Caroline Kurtz; Ahsan Alam; Mark Busbridge; Ulrike Raff; Josef Zimmermann; Peter U Heuschmann; Christoph Wanner; Lothar Schramm
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

Review 5.  The Influence of Inflammation on Anemia in CKD Patients.

Authors:  Anna Gluba-Brzózka; Beata Franczyk; Robert Olszewski; Jacek Rysz
Journal:  Int J Mol Sci       Date:  2020-01-22       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.